Literature DB >> 27888379

Medical Co-morbidities Among Patients with Severe Mental Illnesses in a Community Health Facility in Nigeria.

Victor Olufolahan Lasebikan1, Joachim Azegbeobor2.   

Abstract

To examine prevalence of medical comorbidity (MCM) in schizophrenia (n = 1310) and in bipolar disorder (n = 1307) and the association of high burden of MCM (≥3 MCM) with duration of untreated illness, number of episodes, functioning, poly-medication and lifetime hospitalization for the mental disorder. Participants were recruited from a private psychiatric facility in Ibadan, Nigeria between 2004 and 2013 and enquiry made about the lifetime occurrence of 20 common chronic diseases including common tropical diseases. Psychiatric diagnosis was made using the Structured Clinical Interview for DSM IV Axis I disorder (SCID). Except for nutritional anemia, dermatitis and intestinal Helminthiasis, patients with schizophrenia were not at higher odds of reporting MCM than those with bipolar disorder. DUI ≥2 years, episodes of illness ≥3, being on multiple neuroleptics and history of previous hospitalization were significantly associated with high burden of MCM in schizophrenia and episodes of illness ≥3, reduced functioning and history of previous hospitalization with bipolar disorder. Schizophrenia and bipolar disorder are associated with high rates of medical comorbidity. Treatment of this medical comorbidity is essential in order to improve the outcomes for patients with bipolar disorder and schizophrenia.

Entities:  

Keywords:  Bipolar disorder; Infections; Medical-co-morbidity; Nutritional anaemia; Schizophrenia

Mesh:

Year:  2016        PMID: 27888379     DOI: 10.1007/s10597-016-0063-x

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  61 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

Review 3.  Lithium: a review of its metabolic adverse effects.

Authors:  Callum Livingstone; Hagan Rampes
Journal:  J Psychopharmacol       Date:  2005-09-20       Impact factor: 4.153

4.  Community study of knowledge of and attitude to mental illness in Nigeria.

Authors:  Oye Gureje; Victor O Lasebikan; Olusola Ephraim-Oluwanuga; Benjamin O Olley; Lola Kola
Journal:  Br J Psychiatry       Date:  2005-05       Impact factor: 9.319

5.  Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain.

Authors:  M C Langlois; G Beaudry; H Zekki; C Rouillard; D Lévesque
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 6.  Inequalities in healthcare provision for people with severe mental illness.

Authors:  David Lawrence; Stephen Kisely
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

Review 7.  Physical illness and schizophrenia: a review of the literature.

Authors:  S Leucht; T Burkard; J Henderson; M Maj; N Sartorius
Journal:  Acta Psychiatr Scand       Date:  2007-11       Impact factor: 6.392

8.  Association of co-occurring serious mental illness with emergency hospitalization in people with chronic kidney disease.

Authors:  Sterling McPherson; Celestina Barbosa-Leiker; Kenn Daratha; Robert Short; Michael G McDonell; Radica Alicic; John Roll; Katherine Tuttle
Journal:  Am J Nephrol       Date:  2014-03-19       Impact factor: 3.754

9.  A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence.

Authors:  Golam M Khandaker; Stanley Zammit; Glyn Lewis; Peter B Jones
Journal:  Schizophr Res       Date:  2013-11-22       Impact factor: 4.939

Review 10.  Eating disorders in schizophrenia: implications for research and management.

Authors:  Youssef Kouidrat; Ali Amad; Jean-Daniel Lalau; Gwenole Loas
Journal:  Schizophr Res Treatment       Date:  2014-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.